Physostigmine reversal of benzquinamide-induced delirium.
D000293:Adolescent; D002490:Central Nervous System / Q000187:drug effects; D003693:Delirium / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006801:Humans; D010830:Physostigmine / Q000627:therapeutic use*; D011807:Quinolizines / Q000009:adverse effects* / Q000037:antagonists & inhibitors
D011807:Quinolizines; D010830:Physostigmine